HUTCHMED (China) Limited

AIM:HCM 주식 보고서

시가총액: UK£2.4b

HUTCHMED (China) 관리

관리 기준 확인 4/4

HUTCHMED (China) CEO는 Wei-Guo Su, Jan2012 에 임명되었습니다 의 임기는 12.83 년입니다. 총 연간 보상은 $ 2.45M, 32.5% 로 구성됩니다. 32.5% 급여 및 67.5% 보너스(회사 주식 및 옵션 포함). 는 £ 11.64M 가치에 해당하는 회사 주식의 0.49% 직접 소유합니다. 11.64M. 경영진과 이사회의 평균 재임 기간은 각각 6.5 년과 7.7 년입니다.

주요 정보

Wei-Guo Su

최고 경영자

US$2.5m

총 보상

CEO 급여 비율32.5%
CEO 임기12.8yrs
CEO 소유권0.5%
경영진 평균 재임 기간6.5yrs
이사회 평균 재임 기간7.7yrs

최근 관리 업데이트

Recent updates

HUTCHMED (China) Limited's (LON:HCM) 27% Jump Shows Its Popularity With Investors

Oct 19
HUTCHMED (China) Limited's (LON:HCM) 27% Jump Shows Its Popularity With Investors

Health Check: How Prudently Does HUTCHMED (China) (LON:HCM) Use Debt?

Sep 10
Health Check: How Prudently Does HUTCHMED (China) (LON:HCM) Use Debt?

Analysts Have Made A Financial Statement On HUTCHMED (China) Limited's (LON:HCM) Half-Year Report

Aug 02
Analysts Have Made A Financial Statement On HUTCHMED (China) Limited's (LON:HCM) Half-Year Report

HUTCHMED (China) Limited's (LON:HCM) P/S Still Appears To Be Reasonable

Jul 11
HUTCHMED (China) Limited's (LON:HCM) P/S Still Appears To Be Reasonable

We Think HUTCHMED (China) (LON:HCM) Can Manage Its Debt With Ease

Apr 04
We Think HUTCHMED (China) (LON:HCM) Can Manage Its Debt With Ease

HUTCHMED (China) Limited's (LON:HCM) P/S Is Still On The Mark Following 31% Share Price Bounce

Mar 14
HUTCHMED (China) Limited's (LON:HCM) P/S Is Still On The Mark Following 31% Share Price Bounce

The HUTCHMED (China) Limited (LON:HCM) Analysts Have Been Trimming Their Sales Forecasts

Mar 01
The HUTCHMED (China) Limited (LON:HCM) Analysts Have Been Trimming Their Sales Forecasts

Market Cool On HUTCHMED (China) Limited's (LON:HCM) Revenues

Dec 18
Market Cool On HUTCHMED (China) Limited's (LON:HCM) Revenues

HUTCHMED (China) (LON:HCM) Is Using Debt Safely

Nov 23
HUTCHMED (China) (LON:HCM) Is Using Debt Safely

Does HUTCHMED (China) (LON:HCM) Have A Healthy Balance Sheet?

Aug 24
Does HUTCHMED (China) (LON:HCM) Have A Healthy Balance Sheet?

Is HUTCHMED (China) (LON:HCM) A Risky Investment?

May 10
Is HUTCHMED (China) (LON:HCM) A Risky Investment?

With HUTCHMED (China) Limited (LON:HCM) It Looks Like You'll Get What You Pay For

Apr 19
With HUTCHMED (China) Limited (LON:HCM) It Looks Like You'll Get What You Pay For

CEO 보상 분석

Wei-Guo Su 의 보수는 HUTCHMED (China) 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$42m

Mar 31 2024n/an/a

US$29m

Dec 31 2023US$2mUS$798k

US$101m

Sep 30 2023n/an/a

US$36m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$195m

Dec 31 2022US$4mUS$700k

-US$361m

Sep 30 2022n/an/a

-US$308m

Jun 30 2022n/an/a

-US$255m

Mar 31 2022n/an/a

-US$235m

Dec 31 2021US$3mUS$395k

-US$195m

Sep 30 2021n/an/a

-US$187m

Jun 30 2021n/an/a

-US$178m

Mar 31 2021n/an/a

-US$151m

Dec 31 2020US$1mUS$346k

-US$126m

Sep 30 2020n/an/a

-US$117m

Jun 30 2020n/an/a

-US$110m

Mar 31 2020n/an/a

-US$102m

Dec 31 2019US$1mUS$274k

-US$106m

Sep 30 2019n/an/a

-US$93m

Jun 30 2019n/an/a

-US$87m

Mar 31 2019n/an/a

-US$83m

Dec 31 2018US$1mUS$273k

-US$75m

Sep 30 2018n/an/a

-US$72m

Jun 30 2018n/an/a

-US$61m

Mar 31 2018n/an/a

-US$39m

Dec 31 2017US$2mUS$310k

-US$27m

보상 대 시장: Wei-Guo 의 총 보상 ($USD 2.45M )은 UK 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.68M ).

보상과 수익: Wei-Guo 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Wei-Guo Su (66 yo)

12.8yrs

테뉴어

US$2,451,164

보상

Dr. Wei-Guo Su, B.Sc., Ph D., has been the Chief Executive Officer of HUTCHMED (China) Limited since March 04, 2022. Dr. Su has been the Chief Scientific Officer and Executive Vice President of HUTCHMED (C...

리더십 팀

이름위치테뉴어보상소유권
Wei-Guo Su
CEO, Chief Scientific Officer & Executive Director12.8yrsUS$2.45m0.49%
£ 11.6m
Chig Fung Cheng
CFO & Executive Director16.3yrsUS$962.15k0.18%
£ 4.3m
Edith Shih
Company Secretary & Non-Executive Director18.8yrs데이터 없음데이터 없음
Yiling Cui
Executive VP & Head of Operationsless than a year데이터 없음데이터 없음
David Ng
Head of Investor Relations & Capital Strategiesno data데이터 없음데이터 없음
Charles George Rupert Nixon
Group General Counsel9.5yrs데이터 없음데이터 없음
Kin Hung Lee
Senior Vice President of Corporate Management & Communications1.8yrs데이터 없음데이터 없음
Selina Zhang
Senior Vice President of Global Human Resources2.8yrs데이터 없음데이터 없음
Qingmei Wang
Senior Vice President of Business Development & Strategic Alliancesno data데이터 없음데이터 없음
Zhenping Wu
Executive Vice President of Pharmaceutical Science & Manufacturing12.8yrs데이터 없음데이터 없음
Thomas Fu
Senior Vice President of Global Quality3.6yrs데이터 없음데이터 없음
Ming Shi
Executive VP2.3yrs데이터 없음데이터 없음

6.5yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: HCM 의 관리팀은 노련하고 경험 (평균 재직 기간 6.5 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Wei-Guo Su
CEO, Chief Scientific Officer & Executive Director7.7yrsUS$2.45m0.49%
£ 11.6m
Chig Fung Cheng
CFO & Executive Director13.8yrsUS$962.15k0.18%
£ 4.3m
Edith Shih
Company Secretary & Non-Executive Director18.8yrs데이터 없음데이터 없음
Dan Eldar
Non-Executive Chairman8.3yrs데이터 없음0.013%
£ 304.6k
Ling Yang
Non-Executive Director1.3yrs데이터 없음데이터 없음
Graeme Allan Jack
Independent Non-Executive Director7.7yrsUS$111.00k0.0053%
£ 126.9k
Paul Rutherford Carter
Senior Independent Non-Executive Director7.8yrsUS$117.00k0.0087%
£ 205.8k
Shu Kam Mok
Independent Non-Executive Director7.1yrsUS$114.86k0.011%
£ 265.9k
Renu Bhatia
Independent Non-Executive Directorless than a year데이터 없음데이터 없음

7.7yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: HCM 의 이사회는 경험(평균 재직 기간 7.7 년)으로 간주됩니다.